Evidence map›Paper›PMID 21523820›Full record

ArticleMagnetic resonance in medicine2011

In vivo and ex vivo MR imaging of slowly cycling melanoma cells.

S Magnitsky, A Roesch, M Herlyn, J D Glickson

Open access · bronzeAbstract read
In one paragraph

Article in Magnetic resonance in medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

S MagnitskyLaboratory of Molecular Imaging, Department of Radiology, Philadelphia, Pennsylvania, USA. magnitsk@mail.med.upenn.edu
A Roesch
M Herlyn
J D Glickson
Saarland University · DEThe Wistar Institute · USUniversity of Pennsylvania · US

Funding

UNIVERSITY OF PENNSYLVANIA CAN CTR SUPPORT GRANTP30CA016520 · NCI · UNIVERSITY OF PENNSYLVANIA · PI SHELLEY L BERGER · 1985 to 2026
$222.3M
TUMOR DEVELOPMENT AND PROGRESSION IN HUMAN MELANOCYTESP01CA025874 · NCI · WISTAR INSTITUTE · PI HERLYN, MEENHARD F · 1985 to 2015
$19.0M
METASTATIS: BIOLOGICAL PHENOTYPE AND MODELS FOR THERAPYR01CA047159 · NCI · WISTAR INSTITUTE · PI HERLYN, MEENHARD F · 1989 to 2015
$3.9M
Penn Small Animal Imaging Resource (Penn-SAIR)U24CA083105 · NCI · UNIVERSITY OF PENNSYLVANIA · PI CHODOSH, LEWIS A, GLICKSON, JERRY D · 2007 to 2011
$2.1M
STEROID INDUCED CHANGES IN CULTURED MALIGNANT CELLSR01CA008315 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI MELNYKOVYCH, GEORGE · 1985 to 1993
–
NCI NIH HHS 5U24CA08315-07NCI NIH HHS CA25874NCI NIH HHS CA47159NCI NIH HHS P01 CA025874NCI NIH HHS P30 CA016520NCI NIH HHS R01 CA047159NCI NIH HHS U24 CA083105
6 · The paper itself

Abstract

Slowly cycling cells are believed to play a critical role in tumor progression and metastatic dissemination. The goal of this study was to develop a method for in vivo detection of slowly cycling cells. To distinguish these cells from more rapidly proliferating cells that constitute the vast majority of cells in tumors, we used the well-known effect of label dilution due to division of cells with normal cycle and retention of contrast agent in slowly dividing cells. To detect slowly cycling cells, melanoma cells were labeled with iron oxide particles. After labeling, we observed dilution of contrast agent in parallel with cell proliferation in the vast majority of normally cycling cells. A small and distinct subpopulation of iron-retaining cells was detected by flow cytometry after 20 days of in vitro proliferation. These iron-retaining cells exhibited high expression of a biological marker of slowly cycling cells, JARID1B. After implantation of labeled cells as xenografts into immunocompromised mice, iron-retaining cells were detected in vivo and ex vivo by magnetic resonance imaging that was confirmed by Prussian Blue staining. Magnetic resonance imaging detects not only iron retaining melanoma cells but also iron positive macrophages. Proposed method opens up opportunities to image subpopulation of melanoma cells, which is critical for continuous tumor growth.

Indexed as

Magnetic Resonance ImagingAnimalsCell CycleColoring AgentsContrast MediaFerric CompoundsFerrocyanidesFlow CytometryHumansIronMelanoma, ExperimentalMiceNeoplasm TransplantationPhantoms, ImagingTransplantation, HeterologousColoring AgentsContrast MediaFerric Compoundsferric ferrocyanideferric oxideFerrocyanidesIron

Identifiers

PMID21523820
PMCPMC3145816
OpenAlexW2026719266

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.